Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Splicing-driven post-translational dysregulation: a new frontier for precision cancer medicine and immunotherapy. | Clin Transl Oncol | 2026 | 41580475 | PubTator, text mining | PubMed |
| Clinical Characteristics, Molecular Analysis and Survival Outcomes of Patients With Extramedullary Acute Myeloid Leukemia: A Retrospective Single-Center Study. | Clin Lymphoma Myeloma Leuk | 2026 | 41580336 | PubTator, text mining | PubMed |
| Sequence-dependent splicing dysregulation drives therapy resistance in pediatric AML. | Cell Rep Med | 2026 | 41564858 | PubTator, text mining | PubMed |
| Impact of Mutational Landscape and Burden on RBC Transfusion Response in Patients With Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the COMMANDS Study. | Am J Hematol | 2026 | 41549790 | PubTator, text mining | PubMed |
| Causal splicing variants revealed by deep-learning integration of single-cell sQTL mapping under influenza infection. | Res Sq | 2026 | 41542048 | PubTator, text mining | PubMed |
| Dual FLT3/PIM inhibitor dapolsertib in acute myeloid leukemia: results from the phase 1/2 DIAMOND-01 trial. | Blood Neoplasia | 2026 | 41536779 | PubTator, text mining | PubMed |
| Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY study. | Leukemia | 2026 | 41535568 | PubTator, text mining | PubMed |
| Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms. | J Immunother Cancer | 2026 | 41529908 | PubTator, text mining | PubMed |
| MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities. | Blood Adv | 2026 | 41529224 | PubTator, text mining | PubMed |
| The landscape and evolution of clonal hematopoiesis in chronic lymphocytic leukemia. | Blood | 2026 | 41528026 | PubTator, text mining | PubMed |
| Sequence determinants of RNA G-quadruplex unfolding by Arg-rich regions. | FEBS Lett | 2026 | 41510641 | PubTator, text mining | PubMed |
| Genomic profiles of myelodysplastic neoplasm with bone marrow eosinophilia or basophilia: Inflammatory drivers and DNA damage response. | Leuk Res | 2026 | 41468841 | PubTator, text mining | PubMed |
| Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients. | Leukemia | 2026 | 41145671 | PubTator, text mining | PubMed |
| Clonal Hematopoiesis in Nonmalignant Disease: Functional Consequences of Mutated Immune Cells by Clonal Hematopoiesis in the Diseased Tissue. | Annu Rev Pathol | 2026 | 40929507 | PubTator, text mining | PubMed |
| Clonal haematopoiesis of indeterminate potential and mortality in coronary artery disease. | Eur Heart J | 2026 | 40900105 | PubTator, text mining | PubMed |
| A mammalian, glutaminase-free asparaginase enhances venetoclax activity in preclinical AML models with chromosome 7 deletion. | Front Oncol | 2025 | 41743183 | PubTator, text mining | PubMed |
| Immune activation and microenvironmental crosstalk in hairy cell leukemia. | Front Immunol | 2025 | 41726184 | PubTator, text mining | PubMed |
| Case Report: Novel molecular characterization of rare primary mucinous adenocarcinoma of the renal pelvis. | Front Oncol | 2025 | 41602392 | PubTator, text mining | PubMed |
| [BCR::ABL-Negative Triple Negative Myeloproliferative Neoplasm --Review]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 41502292 | PubTator, text mining | PubMed |
| Prognostic impact of lymphocyte to monocyte ratio in patients with myelodysplastic neoplasms/syndromes. | Blood Res | 2025 | 41454166 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=5